Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entacapone Extension Study in Parkinson's Disease
NCT00237263Phase 2Completed
- Sponsor
- Novartis
- Start
- Feb 2003
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of entacapone in Parkinson's disease (PD), sponsored by Novartis. Started Feb 2003; status: completed.
02
Drugs
entacapone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00237263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00237263.